W Frishman, R Silverman, J Strom, U Elkayam, E Sonnenblick. Show Affiliations »
Abstract
Mesh: See more » Adrenergic beta-Antagonists/administration & dosageAdrenergic beta-Antagonists/adverse effectsAdrenergic beta-Antagonists/therapeutic useArrhythmias, Cardiac/chemically inducedBronchi/drug effectsCentral Nervous System Diseases/chemically inducedDeafness/chemically inducedDrug EruptionsDrug HypersensitivityEye Diseases/chemically inducedGastrointestinal Diseases/chemically inducedHeart Block/chemically inducedHeart Diseases/chemically inducedHeart Failure/chemically inducedHumansHypoglycemia/chemically inducedNeoplasms/chemically inducedNeuromuscular Junction/drug effectsPeritonitis/chemically inducedPractolol/administration & dosagePractolol/adverse effectsPractolol/therapeutic usePropranolol/administration & dosagePropranolol/adverse effectsPropranolol/therapeutic useRaynaud Disease/chemically inducedSubstance Withdrawal Syndrome
Substances: See more » Adrenergic beta-AntagonistsPropranololPractolol
Year: 1979 PMID: 36744 DOI: 10.1016/0002-8703(79)90229-1
Source DB: PubMed Journal: Am Heart J ISSN: 0002-8703 Impact factor: 4.749